Emerging technologies bring not just profound opportunities but also vexing ethical dilemmas, involving issues such as privacy, consent, and access. In healthcare and medicine this challenge is particular profound, rife as it is with opportunities to capitalize on people’s challenges, weaknesses and frailties.
Today’s guest, Michelle Meyer, is a bioethicist and legal scholar who seeks to bring clarity and structure to this important and ever-more-complicated space. She has been serving as the Director of Bioethics Policy, Clarkson-Icahn School of Medicine at Mt. Sinai Bioethics Program but is now on her way to Geisinger Health System where she will continue her research and serve as Associate Director for Research Ethics with a particular focus on Learning Healthcare Systems (continuous improvement through data analysis).
Whether discussing the ethics of psychological testing without consumer consent, A/B testing at Facebook, the roles and responsibilities of institutional review boards for clinical trials, or approaches to balancing of privacy and utility in medical data, Michelle brings a consistently independent voice to a conversation that desperately needs her clarity and insight.
This episode of Tech Tonics is sponsored by DNAnexus, the secure and compliant cloud platform that enables enterprise users to analyze, collaborate around, and integrate massive amounts of genetic and other health data.